These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8372722)

  • 1. Possible mechanisms of action of antimalarials in rheumatic disease.
    Cutler DJ
    Agents Actions Suppl; 1993; 44():139-43. PubMed ID: 8372722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases.
    Furst DE
    Lupus; 1996 Jun; 5 Suppl 1():S11-5. PubMed ID: 8803904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimalarials in rheumatic diseases.
    Tett S; Cutler D; Day R
    Baillieres Clin Rheumatol; 1990 Dec; 4(3):467-89. PubMed ID: 2093438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-malarial drugs: possible mechanisms of action in autoimmune disease and prospects for drug development.
    Fox R
    Lupus; 1996 Jun; 5 Suppl 1():S4-10. PubMed ID: 8803903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action.
    Katz SJ; Russell AS
    Curr Opin Rheumatol; 2011 May; 23(3):278-81. PubMed ID: 21448012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from pharmacokinetic and pharmacodynamic studies of hydroxychloroquine.
    Tett S; McLachlan A; Day R; Cutler D
    Agents Actions Suppl; 1993; 44():145-90. PubMed ID: 8372723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells.
    van den Borne BE; Dijkmans BA; de Rooij HH; le Cessie S; Verweij CL
    J Rheumatol; 1997 Jan; 24(1):55-60. PubMed ID: 9002011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphasalazine in rheumatic diseases.
    Dougados M
    Agents Actions Suppl; 1993; 44():197-201. PubMed ID: 8103962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology.
    Schrezenmeier E; Dörner T
    Nat Rev Rheumatol; 2020 Mar; 16(3):155-166. PubMed ID: 32034323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of hydroxychloroquine as an antirheumatic drug.
    Fox RI
    Semin Arthritis Rheum; 1993 Oct; 23(2 Suppl 1):82-91. PubMed ID: 8278823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical pharmacokinetics of slow-acting antirheumatic drugs.
    Tett SE
    Clin Pharmacokinet; 1993 Nov; 25(5):392-407. PubMed ID: 7904547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action of antimalarials in inflammation: induction of apoptosis in human endothelial cells.
    Potvin F; Petitclerc E; Marceau F; Poubelle PE
    J Immunol; 1997 Feb; 158(4):1872-9. PubMed ID: 9029128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy between lysosomotropic amines and cyclosporin A on human T cell responses to an exogenous protein antigen, tetanus toxoid.
    Schultz KR; Nelson D; Bader S
    Bone Marrow Transplant; 1996 Sep; 18(3):625-31. PubMed ID: 8879628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers.
    Smith ER; Klein-Schwartz W
    J Emerg Med; 2005 May; 28(4):437-43. PubMed ID: 15837026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials.
    Gonzalez-Lopez L; Gamez-Nava JI; Jhangri G; Russell AS; Suarez-Almazor ME
    J Rheumatol; 2000 Jan; 27(1):41-6. PubMed ID: 10648016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells.
    Rahim R; Strobl JS
    Anticancer Drugs; 2009 Sep; 20(8):736-45. PubMed ID: 19584707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The treatment of inflammatory rheumatism by antimalarials (chloroquine and hydroxychloroquine)].
    KERUZORE A; COSTE F; DELBARRE F
    Sem Hop; 1960 Apr; 36():999-1007. PubMed ID: 14408658
    [No Abstract]   [Full Text] [Related]  

  • 18. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects.
    Setty AR; Sigal LH
    Semin Arthritis Rheum; 2005 Jun; 34(6):773-84. PubMed ID: 15942912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chloroquine--miscellaneous properties of the antimalarial drug].
    Jarzyna R
    Postepy Hig Med Dosw; 2002; 56(2):169-84. PubMed ID: 12107961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity.
    Romanelli F; Smith KM; Hoven AD
    Curr Pharm Des; 2004; 10(21):2643-8. PubMed ID: 15320751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.